TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11074738

Group type: EXPERIMENTAL
Intervention: Androstenedione (200 mg/d)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Androstenediol (200 mg/d)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 8873543

Group type: EXPERIMENTAL
Intervention: 5.4% desflurane directed to the upper airway
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 5.4% desflurane directed to the lower airway
Number of subjects: 38

Group type: COMPARATOR
Intervention: 2.4% isoflurane directed to the upper airway
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 2.4% isoflurane directed to the lower airway
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Increased desflurane concentration in one lung (11%) while decreasing in the opposite lung (0%)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Simultaneous administration of desflurane to both lungs
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Topical and nebulized lidocaine, glossopharyngeal and superior laryngeal nerve blocks, transtracheal administration of lidocaine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Systemic infusions of 2% lidocaine
Number of subjects: 38
Study: 1527687

Group type: EXPERIMENTAL
Intervention: e‐PTFE barrier membrane
Number of subjects: 11

Group type: COMPARATOR
Intervention: FDDMA barrier
Number of subjects: 11
Study: 4016786

Group type: EXPERIMENTAL
Intervention: Mitomycin plus tamoxifen (MT)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: MT plus fluoxymesterone
Number of subjects: 130
Study: 31551218

Group type: EXPERIMENTAL
Intervention: Acupoint massage combined with acupoint application before LC surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (directly receive LC surgery)
Number of subjects: 0
Study: 29032225

Group type: EXPERIMENTAL
Intervention: Right Ventricular Dysfunction (RVD) identified by elevated central venous pressure (CVP), elevated CVP-pulmonary capillary wedge pressure (PCWP) ratio, decreased pulmonary artery pulsatility index, and decreased right ventricular stroke work index.
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: RR-RVF criteria requiring percutaneous mechanical circulatory support, including elevated CVP and CVP/PCWP and a low cardiac index despite ≥1 inotrope or vasopressor.
Number of subjects: 397
Study: 26746903

Group type: EXPERIMENTAL
Intervention: Referral for a post discharge medicines use review (MUR) with their regular community pharmacist
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard discharge care
Number of subjects: 60
Study: 25348087

Group type: EXPERIMENTAL
Intervention: HA/CMC powder
Number of subjects: 209

Group type: COMPARATOR
Intervention: No adhesion barrier
Number of subjects: 209
Study: 22678319

Group type: EXPERIMENTAL
Intervention: Diclofenac 1 mg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combination of diclofenac and ketamine (0.15 mg/kg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (100-mL isotonic saline)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ketamine (0.15 mg/kg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Diclofenac alone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combination of diclofenac and ketamine
Number of subjects: 80
Study: 20656674

Group type: EXPERIMENTAL
Intervention: Rosiglitazone therapy
Number of subjects: 35531

Group type: EXPERIMENTAL
Intervention: Rosiglitazone therapy (excluding RECORD trial)
Number of subjects: 35531

Group type: EXPERIMENTAL
Intervention: Rosiglitazone therapy (alternative analysis)
Number of subjects: 35531
Study: 17511331

Group type: EXPERIMENTAL
Intervention: Life Story Workshop (2-hour workshops once a week for 10 weeks)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 33
Study: 15714902

Group type: EXPERIMENTAL
Intervention: Patients (ECR and RA)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: ECR
Number of subjects: 2

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 2
Study: 11817768

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) strategies with personalized feedback letter and two telephone counseling calls
Number of subjects: 269

Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 269
Study: 10765125

Group type: COMPARATOR
Intervention: Combination of FU (600 mg/m2/week x 6, followed by a 2-week rest) and LV (500 mg/m2/week x 6 as a 2-hour infusion, followed by a 2-week rest) for 4 cycles (group A)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Combination of FU and LV plus recombinant IFN (3 MU subcutaneously 3 times a week for 1 year) (group B)
Number of subjects: 280
Study: 9116877

Group type: EXPERIMENTAL
Intervention: Herb A
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Herb B
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Herb C
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo (Group A)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo (Group B)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo (Group C)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Asthmatic guinea pigs (Chinese herbs)
Number of subjects: 303
Study: 1994661

Group type: EXPERIMENTAL
Intervention: High-dose diltiazem (mean dose, 329 mg/day)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 6334071

Group type: EXPERIMENTAL
Intervention: pivmecillinam/pivampicillin
Number of subjects: 49

Group type: COMPARATOR
Intervention: co-trimoxazole
Number of subjects: 49
Study: 31569148

Group type: EXPERIMENTAL
Intervention: Short telomere length (TL) in early pregnancy
Number of subjects: 279

Group type: COMPARATOR
Intervention: Longer telomere length (TL) in early pregnancy
Number of subjects: 279
Study: 28904172

Group type: EXPERIMENTAL
Intervention: Daratumumab added to lenalidomide and dexamethasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daratumumab added to bortezomib and dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm with lenalidomide and dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm with bortezomib and dexamethasone
Number of subjects: 0
Study: 25184799

Group type: EXPERIMENTAL
Intervention: Single telephone call by an occupational therapist at a median of 18 days after discharge
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (no telephone call)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Single telephone call by an occupational therapist
Number of subjects: 153
Study: 23322010

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 21
Study: 22025592

Group type: EXPERIMENTAL
Intervention: Moderate or severe TBI
Number of subjects: 729

Group type: EXPERIMENTAL
Intervention: Mild TBI with intracranial hemorrhage
Number of subjects: 729
Study: 18434929

Group type: EXPERIMENTAL
Intervention: Lateral attic reconstruction (LAR) technique
Number of subjects: 25

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 25
Study: 16516357

Group type: EXPERIMENTAL
Intervention: Pentacel
Number of subjects: 433

Group type: COMPARATOR
Intervention: Infanrix-IPV-Hib
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Both
Number of subjects: 433
Study: 15758604

Group type: EXPERIMENTAL
Intervention: Delayed delivery in those up to 30 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective fetocide of one severe IUGR fetus in midtrimester twin pregnancies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent absent or reversed end diastolic flow in the umbilical artery of monochorionic twins
Number of subjects: 0
Study: 10789666

Group type: EXPERIMENTAL
Intervention: Home visits by nurses
Number of subjects: 743
Study: 9293932

Group type: EXPERIMENTAL
Intervention: Parks' anal retractor
Number of subjects: 20

Group type: COMPARATOR
Intervention: No retractor
Number of subjects: 20
Study: 8289096

Group type: EXPERIMENTAL
Intervention: Comprehensive multidisciplinary treatment strategy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Comprehensive multidisciplinary treatment strategy (in intermediate risk subgroup)
Number of subjects: 98
Study: 3511404

Group type: EXPERIMENTAL
Intervention: High-dose parenteral 6-methylprednisolone (MP)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 2465852

Group type: EXPERIMENTAL
Intervention: Induction VBM followed by radiotherapy
Number of subjects: 85

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 85
Study: 31157881

Group type: EXPERIMENTAL
Intervention: 3-month Facebook smoking cessation intervention
Number of subjects: 500

Group type: COMPARATOR
Intervention: Referral to Smokefree.gov (control)
Number of subjects: 500
Study: 29572124

Group type: EXPERIMENTAL
Intervention: 20 mg diazepam
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 50 mg baclofen
Number of subjects: 16

Group type: COMPARATOR
Intervention: Single-pulse TMS
Number of subjects: 16
Study: 28432745

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 3324

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3324
Study: 26178640

Group type: EXPERIMENTAL
Intervention: Text messaging program focused on improving sleep and physical activity (n=44)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Text messaging program focused on smoking cessation (n=72)
Number of subjects: 116
Study: 24099601

Group type: EXPERIMENTAL
Intervention: DNA/rAd5 vaccine
Number of subjects: 2504

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2504
Study: 21420176

Group type: EXPERIMENTAL
Intervention: Azithromycin 1%
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ofloxacin 0.3%
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Gatifloxacin 0.3%
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 0.5%
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control eyes (untreated)
Number of subjects: 24
Study: 18310181

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: No-treatment group
Number of subjects: 66
Study: 16586388

Group type: EXPERIMENTAL
Intervention: Rifaximin (200 mg 3 times daily for 3 days)
Number of subjects: 25
Study: 14959882

Group type: EXPERIMENTAL
Intervention: 14 percent hydrogen peroxide gel strip (Crest Whitestrips Supreme)
Number of subjects: 38

Group type: COMPARATOR
Intervention: 6 percent hydrogen peroxide whitening strip (Crest Whitestrips)
Number of subjects: 38
Study: 11474820

Group type: EXPERIMENTAL
Intervention: Bach-flower remedies
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 9187023

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) intravenous (iv)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) subcutaneous (sc)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Protamine sulphate (PS)
Number of subjects: 0
Study: 8387806

Group type: EXPERIMENTAL
Intervention: Perindoprilat (1 mg over six hours)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Enalaprilat (1.5 mg over six hours)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Intravenous placebo (saline)
Number of subjects: 36
Study: 3544631

Group type: EXPERIMENTAL
Intervention: nadolol 80 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 30203640

Group type: EXPERIMENTAL
Intervention: Circaid Juxtalite® adjustable compression wrap
Number of subjects: 30

Group type: COMPARATOR
Intervention: 15-20 mmHg compression stockings (CS)
Number of subjects: 30
Study: 25854500

Group type: EXPERIMENTAL
Intervention: ACL reconstruction with hamstrings tendon graft
Number of subjects: 32

Group type: COMPARATOR
Intervention: ACL conservative treatment
Number of subjects: 32
Study: 25033066

Group type: EXPERIMENTAL
Intervention: Alendronate (40 mg daily for subjects > 50 kg, 20 mg for 30‐50 kg, 10 mg for 20‐30 kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 40
Study: 22735163

Group type: EXPERIMENTAL
Intervention: Intermittent Diet (ID)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Continuous Diet (CD)
Number of subjects: 25
Study: 19752153

Group type: EXPERIMENTAL
Intervention: Standard KPP
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: KPP with homolateral leg extension
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: KPP with a wobble board and homolateral leg extension
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: One-handed KPP
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: KPP with heterolateral leg extension
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: KPP with a wobble board
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: KPP with one hand
Number of subjects: 32
Study: 18682623

Group type: EXPERIMENTAL
Intervention: Phentolamine mesylate (PM)
Number of subjects: 484

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 484
Study: 15875530

Group type: EXPERIMENTAL
Intervention: Lycopene (30 mg daily for 1 week)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 12885710

Group type: EXPERIMENTAL
Intervention: Iron-fortified fish sauce (10 mL containing 10 mg Fe as NaFeEDTA)
Number of subjects: 152
Study: 11143915

Group type: EXPERIMENTAL
Intervention: Harpagophytum 2,610 mg per day
Number of subjects: 122

Group type: COMPARATOR
Intervention: Diacerhein 100 mg per day
Number of subjects: 122
Study: 9051279

Group type: EXPERIMENTAL
Intervention: Emotion-focused intervention for widowers (N = 23)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Problem-focused intervention for widows (N = 23)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Non-intervention control group (N = 59)
Number of subjects: 46
Study: 8321613

Group type: EXPERIMENTAL
Intervention: Standard feedback
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Skin-temperature biofeedback
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control
Number of subjects: 49
Study: 3523330

Group type: EXPERIMENTAL
Intervention: Intracervical prostaglandin E2 gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31315471

Group type: EXPERIMENTAL
Intervention: Enhanced Holter ECG monitoring (EPM) for 10 days after the event, and at 3 and 6 months
Number of subjects: 281

Group type: COMPARATOR
Intervention: Standard-of-care (SoC) 24h ECG monitoring
Number of subjects: 281
Study: 28723914

Group type: EXPERIMENTAL
Intervention: Dalazatide 30 mcg/dose
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dalazatide 60 mcg/dose
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 26496265

Group type: EXPERIMENTAL
Intervention: Pirfenidone (1800 mg per day) + NAC (1800 mg per day)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo + NAC (1800 mg per day)
Number of subjects: 76
Study: 24617160

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Hot water bottle
Number of subjects: 128
Study: 21884870

Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg loading dose
Number of subjects: 13608

Group type: COMPARATOR
Intervention: Clopidogrel 150 mg
Number of subjects: 13608

Group type: COMPARATOR
Intervention: Prasugrel 10 mg
Number of subjects: 13608
Study: 19604522

Group type: EXPERIMENTAL
Intervention: Low-glycemic index (LGI) diet
Number of subjects: 38

Group type: COMPARATOR
Intervention: High-glycemic index (HGI) diet
Number of subjects: 38
Study: 16770210

Group type: EXPERIMENTAL
Intervention: Microsurgical resection of lumbar juxta facet cysts
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 31
Study: 15585770

Group type: EXPERIMENTAL
Intervention: Zinc doses of 2.2 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Zinc doses of 5.2 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Zinc doses of 10.4 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Zinc doses of 15.2 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Zinc doses of 20.3 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Zinc doses of 30.1 mg
Number of subjects: 8
Study: 11736882

Group type: EXPERIMENTAL
Intervention: UDCA (50 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: CDCA (600 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (nitrendipine 10 mg without bile acids)
Number of subjects: 6
Study: 9596304

Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Budesonide 800 microg
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg and 800 microg
Number of subjects: 159
Study: 7835324

Group type: EXPERIMENTAL
Intervention: Raw potato starch (RPS) 50 g
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Corn flakes (CF) 100 g
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hylon VII high amylomaize starch (HAS) 75 g
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hylon VII high amylomaize starch (HRA) 25 g
Number of subjects: 7

Group type: COMPARATOR
Intervention: Lactulose (10 g)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Wheat bran and oat bran (controls)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Daily administration of RPS for 3 weeks
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Daily administration of HAS for 3 weeks
Number of subjects: 7
Study: 2964327

Group type: EXPERIMENTAL
Intervention: Miglitol 50mg three times daily for 4 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Miglitol (0, 50, 100, 150, or 200mg)
Number of subjects: 33
Study: 30129411

Group type: EXPERIMENTAL
Intervention: Bapineuzumab (IV) in Study 201 and OLE (bapi/bapi)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo in Study 201 and bapineuzumab IV in OLE (placebo/bapi)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Bapineuzumab (SC) and placebo SC
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Bapineuzumab (IV)
Number of subjects: 194
Study: 28075147

Group type: COMPARATOR
Intervention: Activity
Number of subjects: 181

Group type: COMPARATOR
Intervention: Diet & Activity
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control
Number of subjects: 181
Study: 26252343

Group type: EXPERIMENTAL
Intervention: 6-Minute Walk Test (6MWT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walk Test (ISWT)
Number of subjects: 85
Study: 22671278

Group type: EXPERIMENTAL
Intervention: 6% dimethyl sulfoxide-frozen autologous platelets (CPPs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fresh autologous platelets (Control)
Number of subjects: 0
Study: 25572758

Group type: EXPERIMENTAL
Intervention: 8-week yoga program
Number of subjects: 40
Study: 19675034

Group type: EXPERIMENTAL
Intervention: Miniscalpel-needle percutaneous release (group A)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Steroid injection (group B)
Number of subjects: 83
Study: 16311070

Group type: COMPARATOR
Intervention: Serum digoxin concentration (SDC) ≥1.2 ng/ml
Number of subjects: 1366

Group type: COMPARATOR
Intervention: Serum digoxin concentration (SDC) 0.5-1.1 ng/ml
Number of subjects: 1366

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1366

Group type: EXPERIMENTAL
Intervention: Serum digoxin concentration (SDC) 0.5-1.1 ng/ml in women with EF <35%
Number of subjects: 1366

Group type: EXPERIMENTAL
Intervention: Serum digoxin concentration (SDC) 0.5-1.1 ng/ml in women with EF ≥35%
Number of subjects: 1366
Study: 15309451

Group type: EXPERIMENTAL
Intervention: Lycopene tablets
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tomato soup
Number of subjects: 18

Group type: COMPARATOR
Intervention: Tomato juice
Number of subjects: 18
Study: 11576930

Group type: EXPERIMENTAL
Intervention: Treatment with supraphysiological doses of folic acid and vitamins B(6) and B(12)
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4000
Study: 9244210

Group type: EXPERIMENTAL
Intervention: Low-dose ramipril (0.625 mg daily)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Full-dose ramipril (1.25 mg titrated to 10 mg/d)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 7826445

Group type: EXPERIMENTAL
Intervention: CME program including interactive small-group discussion, role playing, videotaped clinical encounters, lecture presentations, and trigger tapes
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: CME program
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (non-participating physicians)
Number of subjects: 57
Study: 2244446

Group type: EXPERIMENTAL
Intervention: Cimetidine (200 mg IV)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Famotidine (20 mg IV)
Number of subjects: 7
Study: 357097

Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isoproterenol sulfate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31982963

Group type: EXPERIMENTAL
Intervention: Paravertebral block (PVB)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 30058959

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg bid plus acetylsalicylic acid 100 mg
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 5 mg bid
Number of subjects: 1905

Group type: COMPARATOR
Intervention: Acetylsalicylic acid 100 mg per day
Number of subjects: 1905
Study: 28422300

Group type: EXPERIMENTAL
Intervention: Atorvastatin LD 80 mg
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Rosuvastatin LD 40 mg
Number of subjects: 145

Group type: COMPARATOR
Intervention: No statin LD (control group)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Low-dose statins (subgroup analysis)
Number of subjects: 145
Study: 25357145

Group type: EXPERIMENTAL
Intervention: Autologous conditioned plasma (ACP) injections
Number of subjects: 52

Group type: COMPARATOR
Intervention: Low-level laser application
Number of subjects: 52
Study: 24176201

Group type: EXPERIMENTAL
Intervention: Cocaine users
Number of subjects: 86

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 86
Study: 23289345

Group type: EXPERIMENTAL
Intervention: JCS‐01 focused ultrasound fat reduction machine treatment on the 1st and 7th days.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group with ultrasound energy turned off during treatments.
Number of subjects: 40